Skip to content
Stay updated with the latest technology trends, gadget revi…

The Zimbabwean Government Declines ‘One-Sided’ American Health Aid Agreement Over Data Concerns

Medical aid image
The proposed US funding was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a substantial US healthcare agreement valued at $367m (272 million pounds) spanning five years because of the United States' insistence on confidential information.

This rejection was revealed following a official document from December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government representative has since explained that the US was demanding access to biological samples for research and commercial gain but was unwilling to guarantee the resulting advantages from any future vaccines.

"We will now turn to the difficult and regrettable process of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has urged further negotiations to find a agreement suitable to both sides so the nation's vital HIV programme can continue.

Wider Context

This rejection comes after a similar situation in Kenya, where a court halted a related deal with the US after concerns were raised about the safety of citizens' medical information.

After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

The agency had administered assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government agreements to boost openness and accountability.

Based on reports, 16 nations in Africa have to date signed similar agreements, constituting more than $18.3bn in committed funds.

Specifics of the Declined Deal

The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana argued the arrangement was "unequal".

"The proposal required Zimbabwe to share its biological resources and data indefinitely, with no equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.

"Effectively, our nation would supply the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our population if a future pandemic arise."

National Interest and Global Health

He also noted that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting frameworks already established via the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.

"This framework is intended to ensure that when a country provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as opposition to America," he added.

"We encourage ongoing dialogue with our American counterparts on how subsequent collaboration might be structured in a manner that honours the independence and dignity of each country."

Medical Community Reaction

Medical experts expressed it recognised the government's concerns, but suggested that negotiations need to persist since a large portion of the nation's Aids initiatives were funded by external financing.

"Where specific concerns arise, such as those relating to information security or implementation frameworks, these can frequently be addressed via technical clarification and negotiated safeguards," the group added.

The halted deal underscores the ongoing tensions between accepting much-needed international aid and protecting a country's data in an increasingly data-driven world.

Written by

Jeremy Burton

Tech journalist with over a decade of experience covering UK innovations and global tech trends.

New Tech UK

Type to search articles.